Extending Cord Blood Transplant to Adults: Dealing With Problems and Results Overall

Seminars in Hematology

Volumn 47, Issue 1, 2010, Pages 86-96

  Brunstein, Claudio G ^a   Laughlin, Mary J ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3A; CYCLOPHOSPHAMIDE; FLUDARABINE; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CD34 SELECTION; COMORBIDITY; COMPARATIVE STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE FREE SURVIVAL; EVENT FREE SURVIVAL; EX VIVO STUDY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; INTERMETHOD COMPARISON; LEUKEMIA REMISSION; MYELOABLATIVE CONDITIONING; NONHUMAN; OVERALL SURVIVAL; PATIENT SAFETY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; RISK ASSESSMENT; T CELL DEPLETION; THERAPY EFFECT; TREATMENT OUTCOME;

ADULT; AGE FACTORS; BLOOD DONORS; CORD BLOOD STEM CELL TRANSPLANTATION; EVIDENCE-BASED MEDICINE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PATIENT SELECTION; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 72449158056     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2009.10.010     Document Type: Article

References (57)

1. Cornetta K., Laughlin M., Carter S., et al. Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT). Biol Blood Marrow Transplant 11 (2005) 149-160
2. Laughlin M.J., Barker J., Bambach B., et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 344 (2001) 1815-1822
3. Rubinstein P., Carrier C., Scaradavou A., et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339 (1998) 1565-1577
4. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351 (2004) 2265-2275
5. Rocha V., Labopin M., Sanz G., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351 (2004) 2276-2285
6. Takahashi S., Iseki T., Ooi J., et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 104 (2004) 3813-3820
7. Atsuta Y., Suzuki R., Nagamura-Inoue T., et al. Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Blood 113 (2009) 1631-1638
8. Eapen M., Rocha V., Scaradavou A., et al. Effect of stem cell source on transplant outcomes in adult patients with acute leukemia: a comparison of unrelated bone marrow, peripheral blood, and cord blood [abstract]. Blood 112 (2008) 151
9. Takahashi S., Ooi J., Tomonari A., et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood 109 (2007) 1322-1330
10. Rocha V., Aversa F., Labopin M., et al. Outcomes of unrelated cord blood and haploidentical stem cell transplantation in adults with acute leukaemia [abstract]. Blood 106 (2005) 92a
11. Hamza N.S., Lisgaris M., Yadavalli G., et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol 124 (2004) 488-498
12. Parkman R., Cohen G., Carter S.L., et al. Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation. Biol Blood Marrow Transplant 12 (2006) 919-927
13. Kumar P., Defor T., Brunstein C., et al. Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia:impact of donor source on survival. Biol Blood Marrow Transplant 14 (2008) 1394-1400
14. Brunstein C.G., Barker J.N., Weisdorf D.J., et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 110 (2007) 3064-3070
15. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 102 (2003) 1915-1919
16. Ballen K.K., Spitzer T.R., Yeap B.Y., et al. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant 13 (2007) 82-89
17. Cutler C., Yeap B., Kao G., et al. Double umbilical cord blood transplantation sunig reduced intensity conditioning: a single-centre experience. Bone Marrow Transplant 41 Suppl 1 (2008) S23
18. Rocha V., Rio B., Garnier F., et al. Reduced intensity conditioning regimen in single unrelated cord blood transplantation in adults with hematological malignant disorders. An Eurocord-Netcord and SFGM-TC survey [abstract]. Blood 108 (2006) 897a
19. Kindwall-Keller T.L., Hegerfeldt Y., Fu P., et al. Prospective phase II study of the biologic assigment one vs. two umbilical cord blood transplant in the reduced intensity conditioning setting. Blood 112 (2008) 684
20. Komatsu T., Narimatsu H., Yoshimi A., et al. Successful engraftment of mismatched unrelated cord blood transplantation following reduced intensity preparative regimen using fludarabine and busulfan. Ann Hematol 86 (2007) 49-56
21. Misawa M., Kai S., Okada M., et al. Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow. Int J Hematol 83 (2006) 74-79
22. Miyakoshi S., Yuji K., Kami M., et al. Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clin Cancer Res 10 (2004) 3586-3592
23. Morii T., Amano I., Tanaka H., et al. Reduced-intensity unrelated cord blood transplantation (RICBT) in adult patients with high-risk hematological malignancies [abstract]. Blood 106 (2005) 444b
24. Yuji K., Miyakoshi S., Kato D., et al. Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma. Biol Blood Marrow Transplant 11 (2005) 314-318
25. Bradley M.B., Satwani P., Baldinger L., et al. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases. Bone Marrow Transplant 40 (2007) 621-631
26. Komatsu T., Narimatsu H., Yoshimi A., et al. Successful engraftment of mismatched unrelated cord blood transplantation following reduced intensity preparative regimen using fludarabine and busulfan. Ann Hematol 86 (2007) 49-54
27. Miyakoshi S., Kami M., Tanimoto T., et al. Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases. Transplantation 84 (2007) 316-322
28. Narimatsu H., Watanabe M., Kohno A., et al. High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan. Bone Marrow Transplant 41 (2008) 753-756
29. Uchida N., Wake A., Takagi S., et al. Umbilical cord blood transplantation after reduced-intensity conditioning for elderly patients with hematologic diseases. Biol Blood Marrow Transplant 14 (2008) 583-590
30. Lim S.H., Esler W.V., Periman P.O., et al. Reduced-intensity umbilical cord blood transplant for older adult patients. Bone Marrow Transplant 42 (2008) 685-686
31. Brunstein C.G., Cantero S., Cao Q., et al. Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation. Biol Blood Marrow Transplant 15 (2009) 214-222
32. Brunstein C.G., Setubal D., Tomblyn M., et al. Umbilical cord blood transplant after reduced intensity conditioning provides outcomes comparable HLA-matched siblings for patients with high risk and advanced acute myeloid leukemia [abstract]. Blood 108 (2006) 183a
33. Rodrigues C.A., Sanz G., Brunstein C.G., et al. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 27 (2009) 256-263
34. Wake A., Uchida N., Ishiwata K., et al. Single institute analysis of reduced intensity cord blood transplanatation from unrelated donors for adulst with advanced lymphoid malignancies. Blood 112 (2008) 685
35. Majhail N.S., Brunstein C.G., Tomblyn M., et al. Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biol Blood Marrow Transplant 14 (2008) 282-289
36. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105 (2005) 1343-1347
37. Barker J.N., Weisdorf D.J., and Wagner J.E. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 344 (2001) 1870-1871
38. De Lima M., McMannis J.D., Saliba R., et al. Double cord transplantation with and without ex-vivo expansion [abstract]. Blood 112 (2008) 63
39. Horwitz M.E., Morris A., Gasparetto C., et al. Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients. Biol Blood Marrow Transplant 14 (2008) 591-594
40. Michalet M., Le Q.H., Robin M., et al. Double cord blood cell hematopoietic stem cell transplantation after standard or reduced intensity conditioning: report of the SFGM-TC registry. Blood 112 (2008) 688
41. Gutman J., Leisenring W., Appelbaum F.R., et al. Decreases relapse rates without excessive transplant related mortality following cord blood transplanatation: a matched cohort analysis comparing myeloablative cord, matched unrelated, and mismatched unrelated donor transplants. Blood 112 (2008) 356
42. Brunstein C.G., Weisdorf D.J., Defor T., et al. Favorable leukemia-free survival (LFS) for adults and children undergoing myeloablative umbilical cord blood (UCB) transplantation with cyclophosphamide (CY), fludarabine (FLU) and total body irradiation (TBI): a single center analysis of 194 patients. Blood 112 (2008) 682
43. Verneris M.R., Brunstein C., DeFor T.E., et al. Risk of relapse (REL) after umbilical cord blood transplantation (UCBT) in patients with acute leukemia: marked reduction in recipients of two units [abstract]. Blood 106 (2005) 93a
44. MacMillan M., Weisdorf D.J., Brunstein C.G., et al. Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood 113 (2009) 2410-2415
45. Kindwall-Keller T.L., Hegerfeldt Y., Fu P., et al. Prospective phase II study of biologic assignment one vs. two unit umbilical cord blood transplant (UCBT) in the reduced-intensity conditioning setting. Blood 112 (2008) 684
46. Brunstein C.G., Barker J.N., Weisdorf D.J., et al. Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transplant 43 (2009) 935-940
47. Delaney C., Brashen-Stein C., Voorhies H., et al. Notch-mediated expansion of human cord blood progenitor cells results in rapid myeloid reconstitution in vivo following myeloablative cord blood transplantation. Blood 112 (2008) 85
48. Frassoni F., Gualandi F., Podesta M., et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol 9 (2008) 831-839
49. Bautista G., Cabrera J.R., Regidor C., et al. Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor. Bone Marrow Transplant 43 (2009) 365-373
50. Fernandez M.N., Regidor C., Cabrera R., et al. Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms. Bone Marrow Transplant 28 (2001) 355-363
51. Fernandez M.N., Regidor C., Cabrera R., et al. Unrelated umbilical cord blood transplants in adults: Early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor. Exp Hematol 31 (2003) 535-544
52. Delaney C., Varnum-Finney B., Aoyama K., et al. Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells. Blood 106 (2005) 2693-2699
53. Broxmeyer H.E., Kohli L., Kim C.H., et al. Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells. J Leukoc Biol 73 (2003) 630-638
54. Broxmeyer H.E., Hangoc G., Cooper S., et al. AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis. Ann N Y Acad Sci 1106 (2007) 1-19
55. Ratajczak J., Reca R., Kucia M., et al. Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow. Blood 103 (2004) 2071-2078
56. Ratajczak M.Z., Reca R., Wysoczynski M., et al. Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells. Leukemia 18 (2004) 1482-1490
57. Wysoczynski M., Kucia M., Ratajczak J., and Ratajczak M.Z. Cleavage fragments of the third complement component (C3) enhance stromal derived factor-1 (SDF-1)-mediated platelet production during reactive postbleeding thrombocytosis. Leukemia 21 (2007) 973-982